Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by Psoriasis Drug Revenue

1.5 Market Analysis by Type

1.5.1 Global Psoriasis Drug Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 External Use

1.5.3 Oral

1.5.4 Injection

1.6 Market by Application

1.6.1 Global Psoriasis Drug Market Share by Application: 2022-2027

1.6.2 Hospital

1.6.3 Drugs Store

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global Psoriasis Drug Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global Psoriasis Drug Market Players Profiles

3.1 AbbVie

3.1.1 AbbVie Company Profile

3.1.2 AbbVie Psoriasis Drug Product Specification

3.1.3 AbbVie Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Johnson & Johnson

3.2.1 Johnson & Johnson Company Profile

3.2.2 Johnson & Johnson Psoriasis Drug Product Specification

3.2.3 Johnson & Johnson Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Bayer

3.3.1 Bayer Company Profile

3.3.2 Bayer Psoriasis Drug Product Specification

3.3.3 Bayer Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Galderma

3.4.1 Galderma Company Profile

3.4.2 Galderma Psoriasis Drug Product Specification

3.4.3 Galderma Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Bristol-Myers Squibb

3.5.1 Bristol-Myers Squibb Company Profile

3.5.2 Bristol-Myers Squibb Psoriasis Drug Product Specification

3.5.3 Bristol-Myers Squibb Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Novartis

3.6.1 Novartis Company Profile

3.6.2 Novartis Psoriasis Drug Product Specification

3.6.3 Novartis Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Pfizer

3.7.1 Pfizer Company Profile

3.7.2 Pfizer Psoriasis Drug Product Specification

3.7.3 Pfizer Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Merz Pharma

3.8.1 Merz Pharma Company Profile

3.8.2 Merz Pharma Psoriasis Drug Product Specification

3.8.3 Merz Pharma Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Valeant

3.9.1 Valeant Company Profile

3.9.2 Valeant Psoriasis Drug Product Specification

3.9.3 Valeant Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 LEO Pharma

3.10.1 LEO Pharma Company Profile

3.10.2 LEO Pharma Psoriasis Drug Product Specification

3.10.3 LEO Pharma Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 GlaxoSmithKline

3.11.1 GlaxoSmithKline Company Profile

3.11.2 GlaxoSmithKline Psoriasis Drug Product Specification

3.11.3 GlaxoSmithKline Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Psoriasis Drug Market Competition by Market Players

4.1 Global Psoriasis Drug Production Capacity Market Share by Market Players (2016-2021)

4.2 Global Psoriasis Drug Revenue Market Share by Market Players (2016-2021)

4.3 Global Psoriasis Drug Average Price by Market Players (2016-2021)

5 Global Psoriasis Drug Production by Regions (2016-2021)

5.1 North America

5.1.1 North America Psoriasis Drug Market Size (2016-2021)

5.1.2 Psoriasis Drug Key Players in North America (2016-2021)

5.1.3 North America Psoriasis Drug Market Size by Type (2016-2021)

5.1.4 North America Psoriasis Drug Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia Psoriasis Drug Market Size (2016-2021)

5.2.2 Psoriasis Drug Key Players in East Asia (2016-2021)

5.2.3 East Asia Psoriasis Drug Market Size by Type (2016-2021)

5.2.4 East Asia Psoriasis Drug Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe Psoriasis Drug Market Size (2016-2021)

5.3.2 Psoriasis Drug Key Players in Europe (2016-2021)

5.3.3 Europe Psoriasis Drug Market Size by Type (2016-2021)

5.3.4 Europe Psoriasis Drug Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia Psoriasis Drug Market Size (2016-2021)

5.4.2 Psoriasis Drug Key Players in South Asia (2016-2021)

5.4.3 South Asia Psoriasis Drug Market Size by Type (2016-2021)

5.4.4 South Asia Psoriasis Drug Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia Psoriasis Drug Market Size (2016-2021)

5.5.2 Psoriasis Drug Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia Psoriasis Drug Market Size by Type (2016-2021)

5.5.4 Southeast Asia Psoriasis Drug Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East Psoriasis Drug Market Size (2016-2021)

5.6.2 Psoriasis Drug Key Players in Middle East (2016-2021)

5.6.3 Middle East Psoriasis Drug Market Size by Type (2016-2021)

5.6.4 Middle East Psoriasis Drug Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa Psoriasis Drug Market Size (2016-2021)

5.7.2 Psoriasis Drug Key Players in Africa (2016-2021)

5.7.3 Africa Psoriasis Drug Market Size by Type (2016-2021)

5.7.4 Africa Psoriasis Drug Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania Psoriasis Drug Market Size (2016-2021)

5.8.2 Psoriasis Drug Key Players in Oceania (2016-2021)

5.8.3 Oceania Psoriasis Drug Market Size by Type (2016-2021)

5.8.4 Oceania Psoriasis Drug Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America Psoriasis Drug Market Size (2016-2021)

5.9.2 Psoriasis Drug Key Players in South America (2016-2021)

5.9.3 South America Psoriasis Drug Market Size by Type (2016-2021)

5.9.4 South America Psoriasis Drug Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World Psoriasis Drug Market Size (2016-2021)

5.10.2 Psoriasis Drug Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World Psoriasis Drug Market Size by Type (2016-2021)

5.10.4 Rest of the World Psoriasis Drug Market Size by Application (2016-2021)

6 Global Psoriasis Drug Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America Psoriasis Drug Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia Psoriasis Drug Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe Psoriasis Drug Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia Psoriasis Drug Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia Psoriasis Drug Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East Psoriasis Drug Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa Psoriasis Drug Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania Psoriasis Drug Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America Psoriasis Drug Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World Psoriasis Drug Consumption by Countries

7 Global Psoriasis Drug Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of Psoriasis Drug (2022-2027)

7.2 Global Forecasted Revenue of Psoriasis Drug (2022-2027)

7.3 Global Forecasted Price of Psoriasis Drug (2022-2027)

7.4 Global Forecasted Production of Psoriasis Drug by Region (2022-2027)

7.4.1 North America Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.2 East Asia Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.3 Europe Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.4 South Asia Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.6 Middle East Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.7 Africa Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.8 Oceania Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.9 South America Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World Psoriasis Drug Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of Psoriasis Drug by Application (2022-2027)

8 Global Psoriasis Drug Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of Psoriasis Drug by Country

8.2 East Asia Market Forecasted Consumption of Psoriasis Drug by Country

8.3 Europe Market Forecasted Consumption of Psoriasis Drug by Countriy

8.4 South Asia Forecasted Consumption of Psoriasis Drug by Country

8.5 Southeast Asia Forecasted Consumption of Psoriasis Drug by Country

8.6 Middle East Forecasted Consumption of Psoriasis Drug by Country

8.7 Africa Forecasted Consumption of Psoriasis Drug by Country

8.8 Oceania Forecasted Consumption of Psoriasis Drug by Country

8.9 South America Forecasted Consumption of Psoriasis Drug by Country

8.10 Rest of the world Forecasted Consumption of Psoriasis Drug by Country

9 Global Psoriasis Drug Sales by Type (2016-2027)

9.1 Global Psoriasis Drug Historic Market Size by Type (2016-2021)

9.2 Global Psoriasis Drug Forecasted Market Size by Type (2022-2027)

10 Global Psoriasis Drug Consumption by Application (2016-2027)

10.1 Global Psoriasis Drug Historic Market Size by Application (2016-2021)

10.2 Global Psoriasis Drug Forecasted Market Size by Application (2022-2027)

11 Global Psoriasis Drug Manufacturing Cost Analysis

11.1 Psoriasis Drug Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of Psoriasis Drug

12 Global Psoriasis Drug Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 Psoriasis Drug Distributors List

12.3 Psoriasis Drug Customers

12.4 Psoriasis Drug Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by Psoriasis Drug Revenue (US$ Million) 2016-2021

Table 6. Global Psoriasis Drug Market Size by Type (US$ Million): 2022-2027

Table 7. External Use Features

Table 8. Oral Features

Table 9. Injection Features

Table 16. Global Psoriasis Drug Market Size by Application (US$ Million): 2022-2027

Table 17. Hospital Case Studies

Table 18. Drugs Store Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. Psoriasis Drug Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. Psoriasis Drug Market Growth Strategy

Table 46. Psoriasis Drug SWOT Analysis

Table 47. AbbVie Psoriasis Drug Product Specification

Table 48. AbbVie Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Johnson & Johnson Psoriasis Drug Product Specification

Table 50. Johnson & Johnson Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Bayer Psoriasis Drug Product Specification

Table 52. Bayer Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Galderma Psoriasis Drug Product Specification

Table 54. Table Galderma Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Bristol-Myers Squibb Psoriasis Drug Product Specification

Table 56. Bristol-Myers Squibb Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Novartis Psoriasis Drug Product Specification

Table 58. Novartis Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Pfizer Psoriasis Drug Product Specification

Table 60. Pfizer Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Merz Pharma Psoriasis Drug Product Specification

Table 62. Merz Pharma Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Valeant Psoriasis Drug Product Specification

Table 64. Valeant Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. LEO Pharma Psoriasis Drug Product Specification

Table 66. LEO Pharma Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. GlaxoSmithKline Psoriasis Drug Product Specification

Table 68. GlaxoSmithKline Psoriasis Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global Psoriasis Drug Production Capacity by Market Players

Table 148. Global Psoriasis Drug Production by Market Players (2016-2021)

Table 149. Global Psoriasis Drug Production Market Share by Market Players (2016-2021)

Table 150. Global Psoriasis Drug Revenue by Market Players (2016-2021)

Table 151. Global Psoriasis Drug Revenue Share by Market Players (2016-2021)

Table 152. Global Market Psoriasis Drug Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players Psoriasis Drug Market Share (2016-2021)

Table 155. North America Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 156. North America Psoriasis Drug Market Share by Type (2016-2021)

Table 157. North America Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 158. North America Psoriasis Drug Market Share by Application (2016-2021)

Table 159. East Asia Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players Psoriasis Drug Market Share (2016-2021)

Table 162. East Asia Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia Psoriasis Drug Market Share by Type (2016-2021)

Table 164. East Asia Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia Psoriasis Drug Market Share by Application (2016-2021)

Table 166. Europe Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players Psoriasis Drug Market Share (2016-2021)

Table 169. Europe Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe Psoriasis Drug Market Share by Type (2016-2021)

Table 171. Europe Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe Psoriasis Drug Market Share by Application (2016-2021)

Table 173. South Asia Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players Psoriasis Drug Market Share (2016-2021)

Table 176. South Asia Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia Psoriasis Drug Market Share by Type (2016-2021)

Table 178. South Asia Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia Psoriasis Drug Market Share by Application (2016-2021)

Table 180. Southeast Asia Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players Psoriasis Drug Market Share (2016-2021)

Table 183. Southeast Asia Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia Psoriasis Drug Market Share by Type (2016-2021)

Table 185. Southeast Asia Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia Psoriasis Drug Market Share by Application (2016-2021)

Table 187. Middle East Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players Psoriasis Drug Market Share (2016-2021)

Table 190. Middle East Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East Psoriasis Drug Market Share by Type (2016-2021)

Table 192. Middle East Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East Psoriasis Drug Market Share by Application (2016-2021)

Table 194. Africa Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players Psoriasis Drug Market Share (2016-2021)

Table 197. Africa Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa Psoriasis Drug Market Share by Type (2016-2021)

Table 199. Africa Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa Psoriasis Drug Market Share by Application (2016-2021)

Table 201. Oceania Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players Psoriasis Drug Market Share (2016-2021)

Table 204. Oceania Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania Psoriasis Drug Market Share by Type (2016-2021)

Table 206. Oceania Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania Psoriasis Drug Market Share by Application (2016-2021)

Table 208. South America Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players Psoriasis Drug Market Share (2016-2021)

Table 211. South America Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 212. South America Psoriasis Drug Market Share by Type (2016-2021)

Table 213. South America Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 214. South America Psoriasis Drug Market Share by Application (2016-2021)

Table 215. Rest of the World Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players Psoriasis Drug Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players Psoriasis Drug Market Share (2016-2021)

Table 218. Rest of the World Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World Psoriasis Drug Market Share by Type (2016-2021)

Table 220. Rest of the World Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World Psoriasis Drug Market Share by Application (2016-2021)

Table 222. North America Psoriasis Drug Consumption by Countries (2016-2021)

Table 223. East Asia Psoriasis Drug Consumption by Countries (2016-2021)

Table 224. Europe Psoriasis Drug Consumption by Region (2016-2021)

Table 225. South Asia Psoriasis Drug Consumption by Countries (2016-2021)

Table 226. Southeast Asia Psoriasis Drug Consumption by Countries (2016-2021)

Table 227. Middle East Psoriasis Drug Consumption by Countries (2016-2021)

Table 228. Africa Psoriasis Drug Consumption by Countries (2016-2021)

Table 229. Oceania Psoriasis Drug Consumption by Countries (2016-2021)

Table 230. South America Psoriasis Drug Consumption by Countries (2016-2021)

Table 231. Rest of the World Psoriasis Drug Consumption by Countries (2016-2021)

Table 232. Global Psoriasis Drug Production Forecast by Region (2022-2027)

Table 233. Global Psoriasis Drug Sales Volume Forecast by Type (2022-2027)

Table 234. Global Psoriasis Drug Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global Psoriasis Drug Sales Revenue Forecast by Type (2022-2027)

Table 236. Global Psoriasis Drug Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global Psoriasis Drug Sales Price Forecast by Type (2022-2027)

Table 238. Global Psoriasis Drug Consumption Volume Forecast by Application (2022-2027)

Table 239. Global Psoriasis Drug Consumption Value Forecast by Application (2022-2027)

Table 240. North America Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 241. East Asia Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 242. Europe Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 243. South Asia Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 245. Middle East Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 246. Africa Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 247. Oceania Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 248. South America Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world Psoriasis Drug Consumption Forecast 2022-2027 by Country

Table 250. Global Psoriasis Drug Market Size by Type (2016-2021) (US$ Million)

Table 251. Global Psoriasis Drug Revenue Market Share by Type (2016-2021)

Table 252. Global Psoriasis Drug Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global Psoriasis Drug Revenue Market Share by Type (2022-2027)

Table 254. Global Psoriasis Drug Market Size by Application (2016-2021) (US$ Million)

Table 255. Global Psoriasis Drug Revenue Market Share by Application (2016-2021)

Table 256. Global Psoriasis Drug Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global Psoriasis Drug Revenue Market Share by Application (2022-2027)

Table 258. Psoriasis Drug Distributors List

Table 259. Psoriasis Drug Customers List





Figure 1. Product Figure

Figure 2. Global Psoriasis Drug Market Share by Type: 2021 VS 2027

Figure 3. Global Psoriasis Drug Market Share by Application: 2021 VS 2027

Figure 4. North America Psoriasis Drug Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 6. North America Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 7. United States Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 8. Canada Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 9. Mexico Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 10. East Asia Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 11. East Asia Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 12. China Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 13. Japan Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 14. South Korea Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 15. Europe Psoriasis Drug Consumption and Growth Rate

Figure 16. Europe Psoriasis Drug Consumption Market Share by Region in 2021

Figure 17. Germany Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 19. France Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 20. Italy Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 21. Russia Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 22. Spain Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 25. Poland Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 26. South Asia Psoriasis Drug Consumption and Growth Rate

Figure 27. South Asia Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 28. India Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia Psoriasis Drug Consumption and Growth Rate

Figure 30. Southeast Asia Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 31. Indonesia Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 32. Thailand Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 33. Singapore Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 35. Philippines Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 36. Middle East Psoriasis Drug Consumption and Growth Rate

Figure 37. Middle East Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 38. Turkey Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 40. Iran Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 42. Africa Psoriasis Drug Consumption and Growth Rate

Figure 43. Africa Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 44. Nigeria Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 45. South Africa Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 46. Oceania Psoriasis Drug Consumption and Growth Rate

Figure 47. Oceania Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 48. Australia Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 49. South America Psoriasis Drug Consumption and Growth Rate

Figure 50. South America Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 51. Brazil Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 52. Argentina Psoriasis Drug Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World Psoriasis Drug Consumption and Growth Rate

Figure 54. Rest of the World Psoriasis Drug Consumption Market Share by Countries in 2021

Figure 55. Global Psoriasis Drug Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global Psoriasis Drug Price and Trend Forecast (2022-2027)

Figure 58. North America Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 59. North America Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 63. Europe Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 71. Africa Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 75. South America Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World Psoriasis Drug Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World Psoriasis Drug Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America Psoriasis Drug Consumption Forecast 2022-2027

Figure 79. East Asia Psoriasis Drug Consumption Forecast 2022-2027

Figure 80. Europe Psoriasis Drug Consumption Forecast 2022-2027

Figure 81. South Asia Psoriasis Drug Consumption Forecast 2022-2027

Figure 82. Southeast Asia Psoriasis Drug Consumption Forecast 2022-2027

Figure 83. Middle East Psoriasis Drug Consumption Forecast 2022-2027

Figure 84. Africa Psoriasis Drug Consumption Forecast 2022-2027

Figure 85. Oceania Psoriasis Drug Consumption Forecast 2022-2027

Figure 86. South America Psoriasis Drug Consumption Forecast 2022-2027

Figure 87. Rest of the world Psoriasis Drug Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of Psoriasis Drug

Figure 89. Manufacturing Process Analysis of Psoriasis Drug

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. Psoriasis Drug Supply Chain Analysis